Larimar Therapeutics, Inc. (LRMR) — Net Income

Annual figures by fiscal year, from SEC filings.

2012: -$13.88M2013: -$14.03M2014: -$36.48M2015: -$74.29M2016: -$57.88M2017: -$52.03M2018: -$61.37M2019: -$23.13M2020: -$42.48M2021: -$50.64M2022: -$35.35M2023: -$36.95M2024: -$80.60M2025: -$165.67M-$165.67M
2012Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$165.67M-105.5%
2024-$80.60M-118.1%
2023-$36.95M-4.5%
2022-$35.35M+30.2%
2021-$50.64M-19.2%
2020-$42.48M-83.7%
2019-$23.13M+62.3%
2018-$61.37M-18.0%
2017-$52.03M+10.1%
2016-$57.88M+22.1%
2015-$74.29M-103.6%
2014-$36.48M-160.1%
2013-$14.03M-1.1%
2012-$13.88M